Application of a semi-automated 96-well format solid-phase extraction, column-switching, fluorescence detection protocol for the determination of alendronate in human urine samples obtained from a bioequivalence study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 3, 2007, Pages 1151-1155

  Apostolou, Constantinos ^a   Dotsikas, Yannis ^a   Kousoulos, Constantinos ^a   Tsatsou, Georgia ^a   Colocouri, Filomila ^a   Soumelas, Georgios Stefanos ^a   Loukas, Yannis L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

96 Well format; Alendronate; Bioequivalence; Column switching; Urine

Indexed keywords

ALENDRONIC ACID; PAMIDRONIC ACID;

ARTICLE; AUTOMATION; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DETERMINATION; DRUG URINE LEVEL; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; URINALYSIS;

ALENDRONATE; AUTOANALYSIS; BONE DENSITY CONSERVATION AGENTS; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; THERAPEUTIC EQUIVALENCY;

EID: 33846811357     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.09.012     Document Type: Article

References (20)

1. Heynen G., Delwaide P., Bijvoet O.L.M., and Franchimont P. Eur. J. Clin. Invest. 12 (1982) 29-35
2. Fleisch H. Eur. Spine J. 12 (2003) S142-S146
3. Porras A.G., Holland S.D., and Gertz B.J. Clin. Pharmacokinet. 36 (1999) 315-328
4. Tsai E.W., Chamberlain S.D., Forsyth R.J., Bell C., Ip D.P., and Brooks M.A. J. Pharm. Biomed. Anal. 12 (1994) 983-991
5. Tsai E.W., Ip D.P., and Brooks M.A. J. Chromatogr. 596 (1992) 217-224
6. De Marco J., Biffar S.E., Reed D.G., and Brooks M.A. J. Pharm. Biomed. Anal. 7 (1989) 1719-1727
7. Han Y.-H.R., and Qin X.-Z. J. Chromatogr. A 719 (1996) 345-352
8. Qin X.-Z., Tsai E., Sakuma T., and Ip S.P. J. Chromatogr. A 686 (1994) 205-212
9. Yun M.-H., and Kwon K.-I. J. Pharm. Biomed. Anal. 40 (2006) 168-172
10. Lin J. Bone 18 (1996) 75-85
11. Kline W.F., Matuszewski B.K., and Bayne W.F. J. Chromatogr. 583 (1992) 183-193
12. Ptacek P., Klima J., and Macek J. J. Chromatogr. B 767 (2002) 111-116
13. Kline W.F., and Matuszewski B.K. J. Chromatogr. 583 (1992) 183-193
14. Daley-Yates P.T., Gifford L.A., and Hoggarth C.R. J. Chromatogr. 490 (1989) 329-338
15. Kang H.-S., Hwang S.-J., Park J.-S., and Kim C.-K. J. Liq. Chromatogr. R. T. 29 (2006) 1589-1600
16. Al Deeb S.K., Hamdan I.I., and Al Najjar S.M. Talanta 64 (2004) 695-702
17. Wong J.A., Renton K.W., Crocker J.F.S., O' Regan P.A., and Acott P.D. Biomed. Chromatogr. 18 (2004) 98-101
18. Guidance for Industry: Bioanalytical Method Validation (2001), US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD
19. Roldán E.J.A., Quattrocchi O., Zanetti D., Piccinni E., Tessler J., Caballero L.E., and Pérez Lloret A. Arzneim.-Forsch. 55 (2005) 93-101
20. Lainesse A., Ozalp Y., Wong H., and Alpan R.S. Arzneim.-Forsch. 54 (2004) 569-572